2015
DOI: 10.1289/ehp.1409342
|View full text |Cite
|
Sign up to set email alerts
|

Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making

Abstract: BackgroundSafety assessment for repeated dose toxicity is one of the largest challenges in the process to replace animal testing. This is also one of the proof of concept ambitions of SEURAT-1, the largest ever European Union research initiative on alternative testing, co-funded by the European Commission and Cosmetics Europe. This review is based on the discussion and outcome of a workshop organized on initiative of the SEURAT-1 consortium joined by a group of international experts with complementary knowledg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
58
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 101 publications
(58 citation statements)
references
References 32 publications
0
58
0
Order By: Relevance
“…While the requirements for the information needed for approval of pharmaceuticals and pesticides are very proscriptive and largely harmonized across the globe, the regulatory regimes for most chemicals in commerce not only vary from country to country, but are also evolving rapidly. 23,24 Identification of “safer alternatives” to products already on the market is yet another challenge whereby no uniform process or standard exists to establish what “safer” means. 1 Human health considerations are frequently behind a desire for an alternative, and weigh heavily into the overall safety considerations for the choice among the alternatives.…”
Section: Resultsmentioning
confidence: 99%
“…While the requirements for the information needed for approval of pharmaceuticals and pesticides are very proscriptive and largely harmonized across the globe, the regulatory regimes for most chemicals in commerce not only vary from country to country, but are also evolving rapidly. 23,24 Identification of “safer alternatives” to products already on the market is yet another challenge whereby no uniform process or standard exists to establish what “safer” means. 1 Human health considerations are frequently behind a desire for an alternative, and weigh heavily into the overall safety considerations for the choice among the alternatives.…”
Section: Resultsmentioning
confidence: 99%
“…Grouping and read-across are encouraged in regulatory submissions for both mono-constituents and UVCBs. 31–33 However, the inherent compositional complexity and variability of many UVCBs creates unique challenges for their grouping and read-across. Regulatory guidelines allow for inclusion of multidimensional data to support read-across submissions; these can include data on biological activity (toxicological and mechanistic) and bioavailability (including metabolite profiling).…”
Section: Discussionmentioning
confidence: 99%
“…The use of AOPs in a read-across context was considered at a workshop held as part of the SEURAT-1 project (Berggren et al, 2015). The goal of the workshop was to increase confidence in read-across using results from alternative methods.…”
Section: Applications For the Aop/moa Frameworkmentioning
confidence: 99%